Sort
21,453 grants matching “tuberculosis”
Tuberculosis Elimination and Laboratory Cooperative Agreements
$1,055,073Karen Macmaster · Michigan State Department Of Health And Human Services · U52 · FY2010 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$1,055,066Charles H Woernle · Alabama State Dept Of Public Health · U52 · FY2012 · PS
Biomarkers to Stratify Risk of Progression from Latent TB Infection to Active
$1,054,927Padmini Salgame · Boston Medical Center · U19 · FY2016 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,054,497Charles H Woernle · Alabama State Dept Of Public Health · U52 · FY2009 · PS
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade
$1,054,279Maureen Murphy-Weiss · Ohio State Department Of Health · U52 · FY2014 · PS
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$1,053,386Charles H Woernle · Alabama State Dept Of Public Health · U52 · FY2007 · PS
India International Center for Excellence in Research
$1,053,276Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Chicago Clinical Trials Unit
$1,053,181Chad J Achenbach · Northwestern University At Chicago · UM1 · FY2024 · AI
Mouse models for paucibacillary persistence
$1,053,123Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2019 · AI
Oxadiazole Inhibitors of Non-Stop Ribosome Rescue to treat MDR Neisseria gonorrhoeae
$1,052,607Michelle M. Butler · Microbiotix, Inc · R01 · FY2021 · AI
Synthesis of Therapeutic Agents for Treatment of Infectious Diseases
$1,052,509Walter Powell · Starks Associates, Inc. · N01 · FY2010 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,051,742Casey W Riley · Virginia State Dept Of Health · U52 · FY2006 · PS
A STINGing vaccine for TB
$1,051,436William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$1,051,286Beth Israel Medical Ctr (New York) · U01 · FY2001 · AI
Clinical Trials Units for NIAID Networks (UM1)
$1,051,232Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2017 · AI
Bronchiectasis and chronic airway infection
$1,050,549Kenneth Olivier · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Host and Microbial risk factors for drug-sensitive and resistant tuberculosis
$1,048,720Mercedes C Becerra · Brigham And Women'S Hospital · U19 · FY2008 · AI
TRAINING AND RESEARCH IN HIV PREVENTION IN RUSSIA
$1,048,247Yale University · D43 · FY2002 · TW
An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples
$1,047,769Timothy Charles Rodwell · University Of California, San Diego · R01 · FY2015 · AI
Genes And Gene Products As Immunoadjuvants
$1,047,553Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Tuberculosis Research Unit
$1,047,535W. Henry Henry Boom · Case Western Reserve University · N01 · FY2010 · AI
Conducting Public Health Research in China
$1,046,976Feng Zijian · Chinese Ctr-Disease Control/Prevention · U01 · FY2017 · GH
Development of Benzotriazine Oxides as Therapeutics for Drug Resistant Tuberculos
$1,046,974Peter B Madrid · Sri International · R56 · FY2010 · AI
Broad spectrum antibacterials selectively targeting an un-drugged site on the ribosome
$1,045,564Charles Testa · Curza Inc · R01 · FY2021 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$1,045,496Charles H Woernle · Alabama State Dept Of Public Health · U52 · FY2013 · PS